| # | Side effect | Count |
|---|---|---|
| 0 | MALIGNANT NEOPLASM PROGRESSION | 497 |
| 1 | PRODUCT USE IN UNAPPROVED INDICATION | 340 |
| 2 | DEATH | 299 |
| 3 | DIARRHOEA | 299 |
| 4 | FATIGUE | 265 |
| 5 | DISEASE PROGRESSION | 243 |
| 6 | DRUG INEFFECTIVE | 242 |
| 7 | NAUSEA | 220 |
| 8 | OFF LABEL USE | 189 |
| 9 | HYPERTENSION | 183 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | DESMOPLASTIC SMALL ROUND CELL TUMOUR | 36 | 0.4138 |
| 1 | ALVEOLAR SOFT PART SARCOMA METASTATIC | 2 | 0.3333 |
| 2 | EXTRASKELETAL MYXOID CHONDROSARCOMA | 3 | 0.2727 |
| 3 | SYNOVIAL SARCOMA METASTATIC | 6 | 0.2500 |
| 4 | CARDIAC VENTRICULAR SCARRING | 3 | 0.2143 |
| 5 | PLEOMORPHIC LIPOSARCOMA | 2 | 0.2000 |
| 6 | SOLITARY FIBROUS TUMOUR | 3 | 0.1875 |
| 7 | GRANULOCYTE-COLONY STIMULATING FACTOR LEVEL INCREASED | 2 | 0.1667 |
| 8 | OSTEOSARCOMA METASTATIC | 15 | 0.1596 |
| 9 | NEUROFIBROSARCOMA | 13 | 0.1327 |